共 50 条
[49]
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study
[J].
Breast Cancer Research and Treatment,
2022, 196
:229-237